ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Relay Therapeutics Inc

Relay Therapeutics Inc (RLAY)

8.94
-0.12
(-1.32%)
At close: July 26 4:00PM
8.94
0.00
( 0.00% )
After Hours: 6:15PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
8.94
Bid
8.64
Ask
9.15
Volume
830,477
8.69 Day's Range 9.19
5.70 52 Week Range 12.63
Market Cap
Previous Close
9.06
Open
9.00
Last Trade
3
@
9.11
Last Trade Time
17:49:58
Financial Volume
$ 7,384,251
VWAP
8.8916
Average Volume (3m)
1,353,672
Shares Outstanding
132,741,677
Dividend Yield
-
PE Ratio
-3.47
Earnings Per Share (EPS)
-2.58
Revenue
31.97M
Net Profit
-341.97M

About Relay Therapeutics Inc

Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, i... Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008 and RLY-1971, as well as its PI3Ka mutant selective program, known as the RLY-PI3K1047 program. Its initiated a Phase 1 clinical trial for RLY-1971 in patients with advanced solid tumors in the first quarter of 2020 and a first-in-human clinical trial of RLY-4008 enriched for patients with advanced solid tumors having oncogenic FGFR2 alterations in the third quarter of 2020. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Relay Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RLAY. The last closing price for Relay Therapeutics was $9.06. Over the last year, Relay Therapeutics shares have traded in a share price range of $ 5.70 to $ 12.63.

Relay Therapeutics currently has 132,741,677 shares outstanding. The market capitalization of Relay Therapeutics is $1.20 billion. Relay Therapeutics has a price to earnings ratio (PE ratio) of -3.47.

RLAY Latest News

Relay Therapeutics Discloses Three New Programs at New Program & Platform Event

3 new programs include 2 genetic disease programs – vascular malformations & Fabry disease – & 1 precision oncology program – NRAS-specific inhibitor Cash guidance remains unchanged, and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.242.758620689668.79.778.3911161399.04489954CS
42.5439.68756.49.775.95513643537.95085168CS
120.232.640642939158.719.775.95513536727.2749681CS
26-0.92-9.330628803259.8611.165.712641157.76847795CS
52-3-25.125628140711.9412.635.711618348.43433184CS
156-25.23-73.836698858634.1738.155.7108825216.12447621CS
260-25.04-73.690406121233.9864.375.794530619.45523292CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CGTXCognition Therapeutics Inc
$ 3.49
(47.26%)
4.67M
RNAZTransCode Therapeutics Inc
$ 0.365
(23.48%)
6.79M
NAMSNewAmsterdam Pharma Company NV
$ 22.49
(19.25%)
18.82k
YIBOPlanet Image International Ltd
$ 3.40
(16.64%)
62.92k
YYGHYY Group Holding Ltd
$ 0.84
(14.60%)
743
VTVTvTv Therapeutics Inc
$ 13.0022
(-38.67%)
33.35k
CEROCERo Therapeutics Holdings Inc
$ 0.169
(-33.98%)
3.64M
TGLTreasure Global Inc
$ 1.40
(-24.32%)
54.67k
LUXHLuxUrban Hotels Inc
$ 0.1586
(-16.96%)
1.31M
GVHGlobavend Holdings Ltd
$ 0.6302
(-13.06%)
47.77k
SLNASelina Hospitality PLC
$ 0.0265
(-11.67%)
25.19M
RNAZTransCode Therapeutics Inc
$ 0.365
(23.48%)
6.79M
CGTXCognition Therapeutics Inc
$ 3.49
(47.26%)
4.67M
TLTiShares 20 plus Year Treasury Bond
$ 92.90
(-0.10%)
3.91M
CEROCERo Therapeutics Holdings Inc
$ 0.169
(-33.98%)
3.64M

Your Recent History

Delayed Upgrade Clock